To comprehensively identify factors involved in Xist regulation, we have performed a CRISPR screen to test all transcription factors for a role in Xist regulation. The identified factors were then extensively characterized with respect to their mode of action at the Xist locus. This analysis revealed two sets of Xist regulators. Early regulators are active when Xist is first upregulated and modulate the probability of Xist activation through the promoter-proximal region. Late regulators remain expressed after X-inactivation has been initiated, are important to maintain high Xist levels and control distal regulatory regions. A subset of early regulators are more abundant in female compared to male cells, suggesting a role in female-specific Xist expression. One of the identified factors is encoded on the X-chromosome, making it a prime candidate for X-dosage dependent Xist regulation. To assess the dosage-dependence of this regulatory interaction we have developed a new method, called CasTuner, that allows tuning endogenous gene expression homogenously across cells. With CasTuner we have assessed the dose-response relationship between Xist and known and newly identified X-linked Xist regulators. After data analysis with the use of a mathematical model, we could show that female specificity can be achieved through a combined action of two different X-linked regulators with distinct dose-response profiles.